Developer docs
API playgroundTry for free, no card

Search company profiles

Tecnoss

Full company profile

uuid003elrv

Namestring
Tecnoss
Legal namestring
Tecnoss S.r.l.
Websiteurl
tecnoss.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Tecnoss S.r.l. is an Italian medical device manufacturer founded in 1998 by Dr. Giuseppe Oliva, specializing in xenogenic biomaterials for bone and soft tissue regeneration. The company is headquartered in Giaveno (Province of Turin), Italy, with a registered office in Turin, and operates a single manufacturing facility producing approximately 300,000 units per year. Its core technology is a patented tissue conditioning and deantigenation process, originally developed by the founder in 1995, which preserves the natural collagen matrix of xenogenic (cross-species) tissue while achieving biocompatibility — the basis for a portfolio of CE-certified medical devices spanning bone substitutes, collagen membranes, dermal matrices, bone pastes, and ready-to-use gel formulations.

The product portfolio is commercialized under two sub-brands: OsteoBiol® (since 2001) dedicated to dental and oral surgery applications, and Tecnoss® (since 2009) serving the hospital and broader regenerative surgery market. Key products include Gen-Os® (Dual-Phase mineral/collagen bone matrix), Putty and MU bone pastes, mp3® (prehydrated ready-to-use biomaterial), Evolution and Special membranes, TSV-Gel (thermosensitive viscosity gel), GTO® (premium-grade biomaterial), and dermal matrices including Tecnoss® Protexa® and Graftygen® Derma. The entire portfolio holds CE 0477 medical device certification (obtained April 2019), succeeding the prior CE 0373 marks granted progressively from March 2000 onward.

Tecnoss generates revenue through one-time sales of medical device biomaterials to dental surgeons, oral surgeons, and hospital surgical departments via a two-step distribution model: products flow through qualified distribution partners in 70 countries worldwide, supported by clinical evidence (231 international publications) and a professional education platform (Bone Biomaterials & Beyond Academy). The company is privately held and founder-controlled, with a registered share capital of €40,000 and 11-50 employees; no external institutional investors, funding rounds, or M&A activity are disclosed. Over 1 million surgical interventions have been documented using OsteoBiol® biomaterials, providing a long clinical track record that underpins the company's brand and regulatory positioning.

Short descriptiontext

Tecnoss S.r.l. is an Italian medical device manufacturer that designs and produces patented xenogenic collagenated biomaterials for bone and soft tissue regeneration, sold under the OsteoBiol® (dental) and Tecnoss® (hospital) brands through a 70-country distribution network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGiaveno, Italy
HQ citystring
Giaveno
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
xenogenic bone grafts, dental regeneration materials, collagen matrices, guided tissue regeneration, bone substitute devices
Industry3 codes
PRIMARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Dental and Orthopedic Biomaterials
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Biomaterial Medical Devices Sales
TypeOne Time License
Description

Tecnoss designs and produces xenogenic biomaterials sold as medical devices under Tecnoss® and OsteoBiol® brands. Revenue is generated through product sales to dental and surgical professionals via international distribution networks.

tecnoss.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1OsteoBiol
Description

Biomaterials brand dedicated to dentistry. Produces xenogenic biomaterials for bone regeneration, including bone substitutes, membranes, collagen felt, bone paste, and other regenerative products. OsteoBiol products are distributed in over 70 countries worldwide.

tecnoss.com
Core offering1 text field

Tecnoss designs, produces, and documents xenogenic biomaterials used as medical devices for bone and soft tissue regeneration. Its portfolio, marketed under the OsteoBiol® (dental) and Tecnoss® (hospital) brands, includes bone substitutes, collagen membranes, dermal matrices, bone pastes, and prehydrated ready-to-use biomaterials manufactured at its facility in Giaveno, Turin, Italy. The products are built on a patented tissue conditioning and deantigenation process that preserves the natural collagen matrix while achieving cross-species biocompatibility.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 1,000,000 surgical procedures performed using OsteoBiol biomaterials
+2 more records
Product overview1 text field

Tecnoss is a medical device company that designs and produces xenogenic biomaterials through its patented tissue conditioning and deantigenation technology. The company operates primarily through two sub-brands: OsteoBiol® (dedicated to dentistry) and Tecnoss® (targeting the hospital medical market). The product portfolio includes bone substitutes, collagen membranes, dermal matrices, and ready-to-use paste formulations. Key products include Gen-Os® (Dual-Phase bone matrix), Putty and MU bone pastes, mp3® (prehydrated biomaterial), TSV-Gel (thermosensitive gel), GTO® (premium biomaterial), and various membrane products (Special, Evolution, Duo-Teck, Button). All products are CE-marked medical devices manufactured at the company's facility in Giaveno, Turin, Italy, producing approximately 300,000 units annually with distribution to over 70 countries.

Product and service13 records
1Gen-Os®
CategoryBone substitute biomaterial
Description

Dual-Phase bone matrix combining mineral and collagen phases, designed to mimic autologous bone for effective bone regeneration in dental and surgical applications.

2Putty Bone Paste
CategoryBone paste biomaterial
Description

Pre-formed bone paste biomaterial for easy application in bone regeneration procedures, providing ready-to-use handling for surgeons.

3MU Bone Paste
CategoryBone paste biomaterial
Description

Bone paste biomaterial designed for bone grafting applications, offering handling characteristics suited to surgical procedures.

4Special Membrane
CategoryCollagen membrane
Description

Resorbable collagen membrane for guided tissue and bone regeneration, providing a biological barrier function over bone grafting procedures.

5Evolution Membrane
CategoryCollagen membrane
Description

Advanced biological barrier membrane for grafting materials, positioned as the state of the art in membranes for regenerative procedures.

6Duo-Teck Collagen Felt
CategoryCollagen felt biomaterial
Description

Collagen felt product combining innovation with simplicity for tissue regeneration applications.

7Button Collagen Felt
CategoryCollagen felt biomaterial
Description

Collagen felt product designed for specific regeneration applications with enhanced handling characteristics.

8mp3®
CategoryPrehydrated bone graft
Description

Prehydrated, collagenated ready-to-use biomaterial that simplifies surgical procedures and reduces preparation time at the chairside.

9Graftygen® Derma
CategoryDermal matrix
Description

Dermal regeneration product for soft tissue repair applications in medical procedures.

10Tecnoss® Protexa®
CategoryDermal matrix
Description

Dermal matrix product establishing a new standard for dermal regeneration applications in hospital/medical use.

11TSV-Gel
CategoryBone graft gel
Description

Biomaterial with thermosensitive viscosity gel technology, delivering improved handling characteristics during surgical application.

12GTO®
CategoryPremium bone graft
Description

Premium biomaterial positioned as the new standard of excellence in the biomaterials market.

13OsteoBiol®
CategoryDental biomaterials product line
Description

Sub-brand of Tecnoss dedicated to dentistry, offering a comprehensive line of xenogenic biomaterials for bone regeneration used by dental surgeons.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Bone Biomaterials & Beyond Academy
Strategic tierMinorTypeOthers
Description

Educational and training partnership with the Bone Biomaterials & Beyond Academy (bbb.academy), providing professional education resources for dental and medical professionals on bone regeneration techniques using OsteoBiol products.

tecnoss.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Dentsply Sirona
TypeBroad incumbent
Description

Largest dental equipment and consumables company globally, with a regenerative/biomaterials segment. Addresses the same dental surgeon customer base with a broader portfolio including implants, prosthetics, and regenerative materials.

TypeDirect peer
Description

Swiss-based privately held leader in dental bone regeneration (Bio-Oss®, Bio-Gide®). Most direct comparable to Tecnoss in product category (xenogenic bone graft substitutes and collagen membranes) and customer base (dental surgeons and oral surgeons).

3Collagen Solutions
TypeEmerging player
Description

UK-based developer and manufacturer of collagen-based biomaterials for medical devices and regenerative medicine. Comparable as a specialist supplier of collagen-based medical device materials for tissue repair and regeneration.

4Straumann
TypeBroad incumbent
Description

Global dental implant leader (Straumann Group) with a regenerative portfolio including botiss products and other biomaterials. Competes with Tecnoss by bundling implants with regenerative materials and leveraging a far larger commercial footprint.

5botiss biomaterials
TypeDirect peer
Description

Germany-based specialist in dental bone and soft tissue regeneration, with comparable product portfolio (bone graft substitutes, membranes, soft tissue grafts) sold through dental distribution networks — a direct competitor in the European dental regeneration segment.

TypeBroad incumbent
Description

Global medical device major with significant advanced wound management and biologics portfolios. Overlaps with Tecnoss in wound healing/skin regeneration products (Protexa®, Graftygen® Derma) and competes at the high end of the regenerative wound care market.

TypeEmerging player
Description

US-based regenerative medicine company focused on placental tissue allografts for wound care and surgical recovery. Comparable as a specialty regenerative biomaterials company pursuing adjacent indications (wound healing, surgical recovery) via biologic materials.

TypeBroad incumbent
Description

Public medical technology company with significant regenerative tissue technologies (Integra® Dermal Regeneration Template, collagen-based wound care). Overlaps with Tecnoss's Tecnoss® Protexa® and Graftygen® Derma in the dermal matrix/wound regeneration space.

TypeBroad incumbent
Description

Global orthopedic and dental medical device major with a regenerative medicine portfolio (including biologics for bone and dental regeneration). Overlaps with Tecnoss in dental bone graft substitutes and adjacent orthopedic biomaterials.

10RTI Surgical
TypeEmerging player
Description

Specialist in sterile biologic implants for orthopedic, sports medicine, and dental surgery, including xenogenic and allograft bone graft products. Comparable in product category (biologic bone substitutes) though larger and more diversified across surgical specialties.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tecnoss

Dental and Orthopedic Biomaterialstecnoss.com

Tecnoss S.r.l. is an Italian medical device manufacturer that designs and produces patented xenogenic collagenated biomaterials for bone and soft tissue regeneration, sold under the OsteoBiol® (dental) and Tecnoss® (hospital) brands through a 70-country distribution network.

What Tecnoss does

Tecnoss S.r.l. is an Italian medical device manufacturer founded in 1998 by Dr. Giuseppe Oliva, specializing in xenogenic biomaterials for bone and soft tissue regeneration. The company is headquartered in Giaveno (Province of Turin), Italy, with a registered office in Turin, and operates a single manufacturing facility producing approximately 300,000 units per year. Its core technology is a patented tissue conditioning and deantigenation process, originally developed by the founder in 1995, which preserves the natural collagen matrix of xenogenic (cross-species) tissue while achieving biocompatibility — the basis for a portfolio of CE-certified medical devices spanning bone substitutes, collagen membranes, dermal matrices, bone pastes, and ready-to-use gel formulations.

The product portfolio is commercialized under two sub-brands: OsteoBiol® (since 2001) dedicated to dental and oral surgery applications, and Tecnoss® (since 2009) serving the hospital and broader regenerative surgery market. Key products include Gen-Os® (Dual-Phase mineral/collagen bone matrix), Putty and MU bone pastes, mp3® (prehydrated ready-to-use biomaterial), Evolution and Special membranes, TSV-Gel (thermosensitive viscosity gel), GTO® (premium-grade biomaterial), and dermal matrices including Tecnoss® Protexa® and Graftygen® Derma. The entire portfolio holds CE 0477 medical device certification (obtained April 2019), succeeding the prior CE 0373 marks granted progressively from March 2000 onward.

Tecnoss generates revenue through one-time sales of medical device biomaterials to dental surgeons, oral surgeons, and hospital surgical departments via a two-step distribution model: products flow through qualified distribution partners in 70 countries worldwide, supported by clinical evidence (231 international publications) and a professional education platform (Bone Biomaterials & Beyond Academy). The company is privately held and founder-controlled, with a registered share capital of €40,000 and 11-50 employees; no external institutional investors, funding rounds, or M&A activity are disclosed. Over 1 million surgical interventions have been documented using OsteoBiol® biomaterials, providing a long clinical track record that underpins the company's brand and regulatory positioning.

Tecnoss firmographics

Firmographics
Name
Tecnoss
Legal name
Tecnoss S.r.l.
Website
https://tecnoss.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
Tecnoss S.r.l. is an Italian medical device manufacturer that designs and produces patented xenogenic collagenated biomaterials for bone and soft tissue regeneration, sold under the OsteoBiol® (dental) and Tecnoss® (hospital) brands through a 70-country distribution network.
Ownership category
akta.pro rank

Tecnoss industry classification

Industry
Product category
Dental and Orthopedic Biomaterials
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Xenogenic bone grafts
  • Dental regeneration materials
  • Collagen matrices
  • Guided tissue regeneration
  • Bone substitute devices

Where Tecnoss is headquartered

Location

Headquarters

HQ city
Giaveno
HQ country
Italy
HQ region
Europe

Offices2 records

Markets served

Tecnoss business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Biomaterial Medical Devices Sales: Tecnoss designs and produces xenogenic biomaterials sold as medical devices under Tecnoss® and OsteoBiol® brands. Revenue is generated through product sales to dental and surgical professionals via international distribution networks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Tecnoss product offering

Product offering

Core offering

Tecnoss designs, produces, and documents xenogenic biomaterials used as medical devices for bone and soft tissue regeneration. Its portfolio, marketed under the OsteoBiol® (dental) and Tecnoss® (hospital) brands, includes bone substitutes, collagen membranes, dermal matrices, bone pastes, and prehydrated ready-to-use biomaterials manufactured at its facility in Giaveno, Turin, Italy. The products are built on a patented tissue conditioning and deantigenation process that preserves the natural collagen matrix while achieving cross-species biocompatibility.

Product overview

Tecnoss is a medical device company that designs and produces xenogenic biomaterials through its patented tissue conditioning and deantigenation technology. The company operates primarily through two sub-brands: OsteoBiol® (dedicated to dentistry) and Tecnoss® (targeting the hospital medical market). The product portfolio includes bone substitutes, collagen membranes, dermal matrices, and ready-to-use paste formulations. Key products include Gen-Os® (Dual-Phase bone matrix), Putty and MU bone pastes, mp3® (prehydrated biomaterial), TSV-Gel (thermosensitive gel), GTO® (premium biomaterial), and various membrane products (Special, Evolution, Duo-Teck, Button). All products are CE-marked medical devices manufactured at the company's facility in Giaveno, Turin, Italy, producing approximately 300,000 units annually with distribution to over 70 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • OsteoBiol: Biomaterials brand dedicated to dentistry. Produces xenogenic biomaterials for bone regeneration, including bone substitutes, membranes, collagen felt, bone paste, and other regenerative products. OsteoBiol products are distributed in over 70 countries worldwide.

Products and services

  • Gen-Os® Dual-Phase bone matrix combining mineral and collagen phases, designed to mimic autologous bone for effective bone regeneration in dental and surgical applications.
  • Putty Bone Paste Pre-formed bone paste biomaterial for easy application in bone regeneration procedures, providing ready-to-use handling for surgeons.
  • MU Bone Paste Bone paste biomaterial designed for bone grafting applications, offering handling characteristics suited to surgical procedures.
  • Special Membrane Resorbable collagen membrane for guided tissue and bone regeneration, providing a biological barrier function over bone grafting procedures.
  • Evolution Membrane Advanced biological barrier membrane for grafting materials, positioned as the state of the art in membranes for regenerative procedures.
  • Duo-Teck Collagen Felt Collagen felt product combining innovation with simplicity for tissue regeneration applications.
  • Button Collagen Felt Collagen felt product designed for specific regeneration applications with enhanced handling characteristics.
  • mp3® Prehydrated, collagenated ready-to-use biomaterial that simplifies surgical procedures and reduces preparation time at the chairside.
  • Graftygen® Derma Dermal regeneration product for soft tissue repair applications in medical procedures.
  • Tecnoss® Protexa® Dermal matrix product establishing a new standard for dermal regeneration applications in hospital/medical use.
  • TSV-Gel Biomaterial with thermosensitive viscosity gel technology, delivering improved handling characteristics during surgical application.
  • GTO® Premium biomaterial positioned as the new standard of excellence in the biomaterials market.
  • OsteoBiol® Sub-brand of Tecnoss dedicated to dentistry, offering a comprehensive line of xenogenic biomaterials for bone regeneration used by dental surgeons.

Quantifiable outcome

  • Over 1,000,000 surgical procedures performed using OsteoBiol biomaterials
  • +2 more outcomes

Companies that use Tecnoss

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Tecnoss technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Tecnoss partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Bone Biomaterials & Beyond AcademyminorOthersEducational and training partnership with the Bone Biomaterials & Beyond Academy (bbb.academy), providing professional education resources for dental and medical professionals on bone regeneration techniques using OsteoBiol products.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Tecnoss competitors and assessment

Company assessment

Broad incumbents

  • Dentsply Sirona: Largest dental equipment and consumables company globally, with a regenerative/biomaterials segment. Addresses the same dental surgeon customer base with a broader portfolio including implants, prosthetics, and regenerative materials.
  • Straumann: Global dental implant leader (Straumann Group) with a regenerative portfolio including botiss products and other biomaterials. Competes with Tecnoss by bundling implants with regenerative materials and leveraging a far larger commercial footprint.
  • Smith+Nephew: Global medical device major with significant advanced wound management and biologics portfolios. Overlaps with Tecnoss in wound healing/skin regeneration products (Protexa®, Graftygen® Derma) and competes at the high end of the regenerative wound care market.
  • Integra LifeSciences: Public medical technology company with significant regenerative tissue technologies (Integra® Dermal Regeneration Template, collagen-based wound care). Overlaps with Tecnoss's Tecnoss® Protexa® and Graftygen® Derma in the dermal matrix/wound regeneration space.
  • Zimmer Biomet: Global orthopedic and dental medical device major with a regenerative medicine portfolio (including biologics for bone and dental regeneration). Overlaps with Tecnoss in dental bone graft substitutes and adjacent orthopedic biomaterials.

Direct peers

  • Geistlich Pharma: Swiss-based privately held leader in dental bone regeneration (Bio-Oss®, Bio-Gide®). Most direct comparable to Tecnoss in product category (xenogenic bone graft substitutes and collagen membranes) and customer base (dental surgeons and oral surgeons).
  • botiss biomaterials: Germany-based specialist in dental bone and soft tissue regeneration, with comparable product portfolio (bone graft substitutes, membranes, soft tissue grafts) sold through dental distribution networks — a direct competitor in the European dental regeneration segment.

Emerging players

  • Collagen Solutions: UK-based developer and manufacturer of collagen-based biomaterials for medical devices and regenerative medicine. Comparable as a specialist supplier of collagen-based medical device materials for tissue repair and regeneration.
  • MiMedx: US-based regenerative medicine company focused on placental tissue allografts for wound care and surgical recovery. Comparable as a specialty regenerative biomaterials company pursuing adjacent indications (wound healing, surgical recovery) via biologic materials.
  • RTI Surgical: Specialist in sterile biologic implants for orthopedic, sports medicine, and dental surgery, including xenogenic and allograft bone graft products. Comparable in product category (biologic bone substitutes) though larger and more diversified across surgical specialties.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Tecnoss social profiles

Digital presence

Tecnoss compliance and trust

Trust signal

Compliance2 records

Tecnoss financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tecnoss leadership team

Management profile

Number of profiles

Profiles1 record

Tecnoss funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tecnoss M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tecnoss

What does Tecnoss do?

Tecnoss designs, produces, and documents xenogenic biomaterials used as medical devices for bone and soft tissue regeneration. Its portfolio, marketed under the OsteoBiol® (dental) and Tecnoss® (hospital) brands, includes bone substitutes, collagen membranes, dermal matrices, bone pastes, and prehydrated ready-to-use biomaterials manufactured at its facility in Giaveno, Turin, Italy. The products are built on a patented tissue conditioning and deantigenation process that preserves the natural collagen matrix while achieving cross-species biocompatibility.

Is Tecnoss a public or private company?

Tecnoss is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Tecnoss founded?

Tecnoss was founded in 1998. It employs 1 to 10 people.

Where is Tecnoss based?

Tecnoss is headquartered in Giaveno, Italy, in the Europe region.

How does Tecnoss make money?

One revenue line is on record: biomaterial Medical Devices Sales.

Who are Tecnoss's main competitors?

Broad incumbents on record are Dentsply Sirona, Straumann, Smith+Nephew, Integra LifeSciences and Zimmer Biomet. Direct peers are Geistlich Pharma and botiss biomaterials. Emerging players are Collagen Solutions, MiMedx and RTI Surgical.

Does Tecnoss have an API?

No public API is recorded for Tecnoss.

What industry is Tecnoss in?

Tecnoss's product category is Dental and Orthopedic Biomaterials. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales